Although epidemiologically, TNF levels are predictive of heart failure mortality [7], a clinical trial in heart failure patients observed a higher hospitalization rate in the group receiving 10 mg/kg infliximab (anti-TNF) compared with the placebo group [8]. Here, TNF is linked to heart failure.